Search
Kalaris Therapeutics Inc
KLRSAdd to Watchlist
2.420USD
+0.060+2.54%
Close 11-06 16:00（ET）
57.60MMarket Cap
LossP/E TTM
After-hours 17:55 (ET)2.430USD-0.030-1.22%
After-hours 17:55 (ET)Today
+2.54%
5 Days
+19.21%
1 Month
-9.02%
6 Months
-52.17%
Year to Date
-71.33%
1 Year
-48.84%
Key Figures
2.360Open
2.660High
7.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
2.360Prev. Close
2.340Low
19.94KTurnover
LossP/E Static
1.01P/B
0.00%Div Yield TTM
-41.43%ROA
11.88052wk High
0.12Volume Ratio
-58.77MNet Profit
23.80MShares
-0.7871EPS TTM
0.14Beta
-66.60%ROE
1.78052wk Low
28.81%Amplitude
--Gross Margin
57.60MMarket Cap
0.30Reward/Risk
5.45%Risk Rate
More news coming soon, stay tuned...
Kalaris Therapeutics Inc's Score
0.08vs previous score
Forecast8.75
Financial Health5.56
Technical5.63
Valuation Dimensions7.26
Institutional Confidence7.00
Risk Assessment3.71
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Kalaris Therapeutics Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.48/-0.50
Revenue / Forecast
--/0.00
Kalaris Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolKLRS
Number of employees6
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Samsara BioCapital, LLC | 54.42% |
| RTW Investments L.P. | 5.46% |
| ElevateBio LLC | 3.05% |
| Paradigm BioCapital Advisors LP | 2.94% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 56.74% |
| Hedge Fund | 8.21% |
| Investment Advisor/Hedge Fund | 7.60% |
| Investment Advisor | 5.68% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Kalaris Therapeutics Inc (KLRS)?
The current price of Kalaris Therapeutics Inc (KLRS) is 2.42.
What is the symbol of Kalaris Therapeutics Inc?
The ticker symbol of Kalaris Therapeutics Inc is KLRS.
What is the 52-week high of Kalaris Therapeutics Inc?
The 52-week high of Kalaris Therapeutics Inc is 11.88.
What is the 52-week low of Kalaris Therapeutics Inc?
The 52-week low of Kalaris Therapeutics Inc is 1.78.
What is the market capitalization of Kalaris Therapeutics Inc?
The market capitalization of Kalaris Therapeutics Inc is 57.60M.
Is Kalaris Therapeutics Inc (KLRS) currently rated as Buy, Hold, or Sell?
According to analysts, Kalaris Therapeutics Inc (KLRS) has an overall rating of Buy, with a price target of 17.67.
What is the Earnings Per Share (EPS TTM) of Kalaris Therapeutics Inc (KLRS)?
The Earnings Per Share (EPS TTM) of Kalaris Therapeutics Inc (KLRS) is -0.79.